Cleared Special

K242374 - ULSPIRA TS™ Nitric Oxide Therapy System (FDA 510(k) Clearance)

Jan 2025
Decision
161d
Days
Class 2
Risk

K242374 is an FDA 510(k) clearance for the ULSPIRA TS™ Nitric Oxide Therapy System. This device is classified as a Apparatus, Nitric Oxide Delivery (Class II - Special Controls, product code MRN).

Submitted by Airgas Therapeutics, LLC (Plumsteadville, US). The FDA issued a Cleared decision on January 17, 2025, 161 days after receiving the submission on August 9, 2024.

This device falls under the Anesthesiology FDA review panel. Regulated under 21 CFR 868.5165.

Submission Details

510(k) Number K242374 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 09, 2024
Decision Date January 17, 2025
Days to Decision 161 days
Submission Type Special
Review Panel Anesthesiology (AN)
Summary Summary PDF

Device Classification

Product Code MRN - Apparatus, Nitric Oxide Delivery
Device Class Class II - Special Controls
CFR Regulation 21 CFR 868.5165